12:00 AM
 | 
Jan 17, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

DaTscan ioflupane I123 Injection regulatory update

FDA approved an NDA from GE's GE Healthcare unit for DaTscan ioflupane I123 injection for the visualization of dopamine transporter (DaT) distribution within the striata by single...

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >